XONELITY

Welcome to the Brand page for “XONELITY”, which is offered here for Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases including schizophrenia, depression, major depressive disorder, treatment resistant depression, bipolar depression, bipolar disorder,mitigation of weight gain, metabolic diseases and dyslipidemia;.

Its status is currently believed to be active. Its class is unavailable. “XONELITY” is believed to be currently owned by “ALKERMES PHARMA IRELAND LIMITED”.

Owner:
ALKERMES PHARMA IRELAND LIMITED
Owner Details
Description:
Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases including schizophrenia, depression, major depressive disorder, treatment resistant depression, bipolar depression, bipolar disorder,mitigation of weight gain, metabolic diseases and dyslipidemia;
Categories: PHARMACEUTICAL PREPARATIONS TREATMENT